Css LLC Aurinia Pharmaceuticals Inc. Put Options Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $18,648 - $34,692	-2,800 Reduced 71.79%	1,100 $8,000
Q2 2022 Aug 15, 2022	BUY	$8.95 - $12.8 $25,059 - $35,840	2,800 Added 254.55%	3,900 $39,000
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $502,500 - $1.12 Million	-50,000 Reduced 97.85%	1,100 $14,000
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $312,928 - $582,208	-17,600 Reduced 25.62%	51,100 $1.17 Million
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $641,591 - $1.38 Million	58,700 Added 587.0%	68,700 $1.52 Million
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $54,079 - $68,306	4,100 Added 69.49%	10,000 $147,000
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $83,308 - $108,146	5,900 New	5,900 $96,000

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.